mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics

Journal of Neuroscience Research

Volumn 79, Issue 6, 2005, Pages 868-878

  Dracheva, Stella ^a,b   McGurk, Susan R ^a   Haroutunian, Vahram ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

AMPA receptor binding proteins; AMPA receptors; Dorsolateral prefrontal cortex; mRNA expression; Occipital cortex; Real time PCR; Schizophrenia

Indexed keywords

AMPA RECEPTOR; BINDING PROTEIN; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 4; GLUTAMIC ACID; MESSENGER RNA; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN ABP; PROTEIN INTERACTING WITH PROTEIN KINASE C; PROTEIN SAP 97; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

AGED; AMPAR GENE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; NEUROTRANSMISSION; NUCLEOTIDE SEQUENCE; OCCIPITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; SCHIZOPHRENIA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARRIER PROTEINS; CEREBRAL CORTEX; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; POSTMORTEM CHANGES; RECEPTORS, AMPA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 16444377948     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20423     Document Type: Article

References (86)

1. Anand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello A, Krystal JH. 2000. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 57:270-276.
2. Bai J, He F, Novikova SI, Undie AS, Dracheva S, Haroutunian V, Lidow MS. 2004. Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins. Biol Psychiatry 56:427-440.
3. Barry MF, Ziff EB. 2002. Receptor trafficking and the plasticity of excitatory synapses. Curr Opin Neurobiol 12:279-286.
4. Beneyto M, Meador-Woodruff JH. 2004. Expression of transcripts encoding AMPA receptor subunits and associated postsynaptic proteins in the macaque brain. J Comp Neurol 468:530-554.
5. Bochet P, Audinat E, Lambolez B, Crepel F, Rossier J, Iino M, Tsuzuki K, Ozawa S. 1994. Subunit composition at the single-cell level explains functional properties of a glutamate-gated channel. Neuron 12:383-388.
6. Bonnet G, Tyagi S, Libchaber A, Kramer FR. 1999. Thermodynamic basis of the enhanced specificity of structured DNA probes. Proc Natl Acad Sci U S A 96:6171-6176.
7. Breese CR, Freedman R, Leonard SS. 1995. Glutamate receptor subtype expression in human post-mortem brain tissue from schizophrenics and alcohol abusers. Brain Res 674:82-90.
8. Burette A, Wyszynski M, Valtschanoff JG, Sheng M, Weinberg RJ. 1999. Characterization of glutamate receptor interacting protein-immunopositive neurons in cerebellum and cerebral cortex of the albino rat. J Comp Neurol 411:601-612.
9. Burette A, Khatri L, Wyszynski M, Sheng M, Ziff EB, Weinberg RJ. 2001. Differential cellular and subcellular localization of AMPA receptor-binding protein and glutamate receptor-interacting protein. J Neurosci 21:495-503.
10. Carlsson A, Waters N. Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML. 2001. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237-260.
11. Celio MR. 1986. Parvalbumin in most gamma-aminobutyric acid-containing neurons of the rat cerebral cortex. Science 231:995-997.
12. Davidson M, Haroutunian V. 1995. Cognitive impairment in geriatric schizophrenic patients: clinical and post-mortem characterization. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press.
13. Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY, Losonczy MF, Keefe RS, Katz S, Frecska E. 1995. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry 152:197-207.
14. DeSouza S, Fu J, States BA, Ziff EB. 2002. Differential palmitoylation directs the AMPA receptor-binding protein ABP to spines or to intracellular clusters. J Neurosci 22:3493-3503.
15. Dingledine R, Borges K, Bowie D, Traynelis SF. 1999. The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
16. Dong H, O'Brien RJ, Fung ET, Lanahan AA, Worley PF, Huganir RL. 1997. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature 386:279-284.
17. Dracheva S, Marras SAE, Kramer FR, Davis KL, Haroutunian V. 2001. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry 158:1400-1410.
18. Dracheva S, Elhakem SL, Marcus SM, Siever LJ, McGurk SR, Haroutunian V. 2003. RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J Neurochem 87:1402-1412.
19. Dracheva S, Elhakem SL, McGurk SR, Davis KL, Haroutunian V. 2004. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J Neurosci Res 76:581-592.
20. Eastwood SL, Porter RH, Harrison PJ. 1996. The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain. Neurosci Lett 212:163-166.
21. Farber NB, Newcomer JW, Olney JW. 1998. The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease. Prog Brain Res 116:421-437.
22. Fitzgerald L, Deutch A, Gasic G, Heinemann S, Nestler E. 1995a. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci 15:2453-2461.
23. Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler EJ. 1995b. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci 15:2453-2461.
24. Gardoni F, Mauceri D, Fiorentini C, Bellone C, Missale C, Cattabeni F, Di Luca M. 2003. CaMKII-dependent phosphorylation regulates SAP97/ NR2A interaction. J Biol Chem 278:44745-44752.
25. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15:193-204.
26. Goff DC, Coyle JT. 2001. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158:1367-1377.
27. Halberstadt AL. 1995. The phencyclidine-glutamate model of schizophrenia. Clin Neuropharmacol 18:237-249.
28. Harrison PJ. 2004. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 174:151-162.
29. Harvey PD, Howanitz E, Parrella M, White L, Davidson M, Mohs RC, Hoblyn J, Davis KL. 1998. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry 155:1080-1086.
30. Healy DJ, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ, Meador-Woodruff JH. 1998. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics. Neropsychopharmacology 19:278-286.
31. Higuchi R, Fockler C, Dollinger G, Watson R. 1993. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology 11:1026-1030.
32. Hollmann M, Heinemann S. 1994. Cloned glutamate receptors. In: Cowan W, Shooter E, Stevens C, Thompson R, editors. Annual review of neuroscience. Palo Alto, CA: Annual Reviews Inc. p 31-108.
33. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252:851-853.
34. Iino M, Ozawa S, Tsuzuki K. 1990. Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones. J Physiol 424:151-165.
35. Javitt D, Zukin S. 1991. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
36. Jonas P, Burnashev N. 1995. Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron 15:987-990.
37. Karnak D, Lee S, Margolis B. 2002. Identification of multiple binding partners for the amino-terminal domain of synapse-associated protein 97. J Biol Chem 277:46730-46735.
38. Kondo M, Sumino R, Okado H. 1997. Combinations of AMPA receptor subunit expression in individual cortical neurons correlate with expression of specific calcium-binding proteins. J Neurosci 17:1570-1581.
39. Kornhuber J, Schnitz A, Wiltfang J, Meineke I, Gleiter CH, Zochling R, Boissl KW, Leblhuber F, Riederer P. 1999. Persistence of haloperidol in human brain tissue. Am J Psychiatry 156:885-890.
40. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremmer JD, Heninger GR, Bowers MB, Charney DS. 1994. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch Gen Psychiatry 51:199-214.
41. Krystal JH, Moghaddam B, Breier A, Goldman-Rakic PS, McElvey J. 1998. Glutamate, dopamine, the frontal cortex, and schizophrenia. Biol Psychiatry 43:605.
42. Krystal JH, D'Souza DC, Petrakis IL, Belger A, Herman RM, Charney DS, Abi-Saab W, Madonick S. 1999. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry 7:125-143.
43. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA. 1995a. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6:869-872.
44. Lahti AC, Koffel B, LaPorte D, Tamminga CA. 1995b. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19.
45. Leonard AS, Davare MA, Horne MC, Garner CC, Hell JW. 1998. SAP97 is associated with the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor GluR1 subunit. J Biol Chem 273:19518-19524.
46. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
47. Malinow R, Malenka RC. 2002. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25:103-126.
48. Marras SA, Kramer FR, Tyagi S. 1999. Multiplex detection of single-nucleotide variations using molecular beacons. Genet Anal 14:151-156.
49. Martin LJ, Blackstone CD, Levey AI, Huganir RL, Price DL. 1993. Cellular localizations of AMPA glutamate receptors within the basal forebrain magnocellular complex of rat and monkey. J Neurosci 13:2249-2263.
50. McCoy L, Cox C, Richfield EK. 1998. Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression. Synapse 28:195-207.
51. Meador-Woodruff JH, Healy DJ. 2000. Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev 31:288-294.
52. Meador-Woodruff JH, King RE, Damask SP, Bovenkerk KA. 1996. Differential regulation of hippocampal AMPA and kainate receptor subunit expression by haloperidol and clozapine. Mol Psychiatry 1:41-53.
53. Moghaddam B, Adams BW. 1998. Reversal of phencyclidine effects by a group 11 metabotropic glutamate receptor agonist in rats. Science 281:1349-1352.
54. Moghaddam B, Adams B, Verma A, Daly D. 1997. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927.
55. Mosbacher J, Schoepfer R, Monyer H, Burnashev N, Seeburg PH, Ruppersberg JP. 1994. A molecular determinant for submillisecond desensitization in glutamate receptors. Science 266:1059-1062.
56. Muller BM, Kistner U, Veh RW, Cases-Langhoff C, Becker B, Gundelfinger ED, Garner CC. 1995. Molecular characterization and spatial distribution of SAP97, a novel presynaptic protein homologous to SAP90 and the Drosophila discs-large tumor suppressor protein. J Neurosci 15:2354-2366.
57. Nakagawa T, Futai K, Lashuel HA, Lo I, Okamoto K, Walz T, Hayashi Y, Sheng M. 2004. Quaternary structure, protein dynamics, and synaptic function of SAP97 controlled by L27 domain interactions. Neuron 44:453-467.
58. Niethammer M, Kim E, Sheng M. 1996. Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J Neurosci 16:2157-2163.
59. Noga JT, Hyde TM, Herman MM, Spurney CF, Bigelow LB, Weinberger DR, Kleinman JE. 1997. Glutamate receptors in the post-mortem striatum of schizophrenic, suicide, and control brains. Synapse 27:168-176.
60. Noga JT, Hyde TM, Bachus SE, Herman MM, Kleinman JE. 2001. AMPA receptor binding in the dorsolateral prefrontal cortex of schizophrenics and controls. Schizophrenia Res 48:361-363.
61. Olney JW, Farber NB. 1995. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13:335-345.
62. Oretti RG, Spurlock G, Buckland PR, McGuffin P. 1994. Lack of effect of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brains. Neurosci Lett 177:39-43.
63. Petralia RS. 1997. Immunochemical localization of ionotropic glutamate receptors (GluRs) in neural circuits. In: Monaghan DT, Wenthold RJ, editors. The ionotropic glutamate receptors. Totawa, NJ: Humana p 219-263.
64. Petralia RS, Wenthold RJ. 1992. Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain. J Comp Neurol 318:329-354.
65. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis K. 1998. Alzheimer's disease and related neurodegenerative diseases in elderly schizophrenic patients. Arch Gen Psychiatry 55:205-211.
66. Ren JQ, Aika Y, Heizmann CW, Kosaka T. 1992. Quantitative analysis of neurons and glial cells in the rat somatosensory cortex, with special reference to GABAergic neurons and parvalbumin-containing neurons. Exp Brain Res 92:1-14.
67. Reuver SM, Garner CC. 1998. E-cadherin mediated cell adhesion recruits SAP97 into the cortical cytoskeleton. J Cell Sci 111:1071-1080.
68. Rosenmund C, Stern-Bach Y, Stevens CF. 1998. The tetrameric structure of a glutamate receptor channel. Science 280:1596-1599.
69. Rumbaugh G, Sia GM, Garner CC, Huganir RL. 2003. Synapse-associated protein-97 isoform-specific regulation of surface AMPA receptors and synaptic function in cultured neurons. J Neurosci 23:4567-4576.
70. Sans N, Racca C, Petralia RS, Wang YX, McCallum J, Wenthold RJ. 2001. Synapse-associated protein 97 selectively associates with a subset of AMPA receptors early in their biosynthetic pathway. J Neurosci 21:7506-7516.
71. Schaffer AA, Aravind L, Madden TL, Shavirin S, Spouge JL, Wolf YI, Koonin EV, Altschul SF. 2002. Improving the accuracy of PSl-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res 29:2994-3005.
72. Sokolov BP. 1998. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics. J Neurochem 71:2454-2464.
73. Srivastava S, Osten P, Vilim FS, Khatri L, Inman G, States B, Daly C, DeSouza S, Abagyan R, Valtschanoff JG, Weinberg RJ, Ziff EB. 1998. Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA receptor-binding protein ABP. Neuron 21:581-591.
74. Tachibana M, Wenthold RJ, Morioka H, Petralia RS. 1994. Light and electron microscopic immunocytochemical localization of AMPA-selective glutamate receptors in the rat spinal cord. J Comp Neurol 344:431-454.
75. Tarazi FI, Florijn WJ, Creese I. 1996. Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology 128:371-379.
76. Tiffany AM, Manganas LN, Kim E, Hsueh YP, Sheng M, Trimmer JS. 2000. PSD-95 and SAP97 exhibit distinct mechanisms for regulating K(+) channel surface expression and clustering. J Cell Biol 148:147-158.
77. Toyooka K, Iritani S, Makifuchi T, Shirakawa O, Kitamura N, Maeda K, Nakamura R, Niizato K, Watanabe M, Kakita A, Takahashi H, Someya T, Nawa H. 2002. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem 83:797-806.
78. Tsuzuki K, Lambolez B, Rossier J, Ozawa S. 2001. Absolute quantification of AMPA receptor subunit mRNAs in single hippocampal neurons. J Neurochem 77:1650-1659.
79. Tyagi S, Kramer FR. 1996. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 14:303-308.
80. van Brederode JF, Helliesen MK, Hendrickson AE. 1991. Distribution of the calcium-binding proteins parvalbumin and calbindin-D28k in the sensorimotor cortex of the rat. Neuroscience 44:157-171.
81. Vet JA, Majithia AR, Marras SA, Tyagi S, Dube S, Poiesz BJ, Kramer FR. 1999. Multiplex detection of four pathogenic retroviruses using molecular beacons. Proc Natl Acad Sci U S A 96:6394-6399.
82. Wenthold RJ, Petralia RS, Blahos J II, Niedzielski AS. 1996. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci 16:1982-1989.
83. Wisden W, Seeburg PH. 1993. Mammalian ionotropic glutamate receptors. Curr Opin Neurobiol 3:291-298.
84. Xia J, Zhang X, Staudinger J, Huganir RL. 1999. Clustering of AMPA receptors by the synaptic PDZ domain-containing protein P1CK1. Neuron 22:179-187.
85. Yamazaki M, Fukaya M, Abe M, Ikeno K, Kakizaki T, Watanabe M, Sakimura K. 2001. Differential palmitoylation of two mouse glutamate receptor interacting protein 1 forms with different N-terminal sequences. Neurosci Lett 304:81-84.
86. Zavitsanou K, Ward PB, Huang XF. 2002. Selective alterations in ionotropic glutamate receptors in the anterior cingulate cortex in schizophrenia. Neuropsychopharmacology 27:826-833.